SAMHSA will award OD Treatment Access funds to Federally Qualified Health Centers (FQHC), Opioid Treatment Programs, or practitioners who have a waiver to prescribe buprenorphine to expand access to Food and Drug Administration (FDA)-approved drugs or devices for emergency treatment of known or suspected opioid overdose.
|Funding Opportunity Title:||Improving Access to Overdose Treatment|
|Funding Opportunity Number:||SP-18-006|
|Due Date for Applications:||June 4, 2018|
|Anticipated Total Available Funding:||Up to $940,000|
|Estimated Number of Awards:||Up to 5|
|Estimated Award Amount:||Up to $200,000 per year|
|Link to Funding Opportunity Announcement||Request for Proposals|
|Anticipated Project Start Date:||September 30, 2018|
|Length of Project Period:||Up to 5 years|
|Eligible Applicants:||SAMHSA is limiting eligibility to FQHCs (as defined in section 1861(aa) of the Social Security Act), opioid treatment programs as defined under part 8 of title 42, Code of Federal Regulations, and practitioners dispensing narcotic drugs pursuant to section 303(g) of the Controlled Substances Act.
[See Section III-1 for complete eligibility information.]